Advanced search
Publication Cover
Journal of Medical Economics Volume 20, 2017 - Issue 5
Submit an article Journal homepage
1,119
Views
5
CrossRef citations to date
0
Altmetric
Surgery

Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study

Charles V. Pollack JrThomas Jefferson University, Philadelphia, PA, USA; Correspondence[email protected]
,
Richard BernsteinNorthwestern University, Chicago, IL, USA;
,
Robert DubielBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA;
,
Paul ReillyBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA;
,
Fredrik GruenenfelderBoehringer Ingelheim Corporation, Ingelheim, Germany;
,
Menno V. HuismanLeiden University Medical Center, Leiden, the Netherlands;
,
Chak-Wah KamTuen Mun Hospital, Tuen Mun, New Territories, Hong Kong, PR China;
,
Eva KleineBoehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany;
,
Jerrold H. LevyDuke University Medical Center, Durham, NC, USA;
,
Frank W. SellkeRhode Island Hospital, Brown Medical School, Providence, RI, USA;
,
Thorsten SteinerKlinik für Neurologie, Klinikum Frankfurt Höchst, Frankfurt and Universitätsklinikum, Heidelberg, Germany;
,
Anastasia UstyugovaBoehringer Ingelheim GmbH, Ingelheim, Germany;
&
Jeffrey I. WeitzMcMaster University and Thrombosis and Atherosclerosis Research Institute, Hamilton, Ontario, Canada
 show all
Pages 435-442 | Received 05 Aug 2016, Accepted 13 Dec 2016, Published online: 17 Jan 2017

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Andrew B Song, Rachel P Rosovsky, Jean M Connors & Hanny Al-Samkari. (2019) Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients. Vascular Health and Risk Management 15, pages 175-186.
Read now
Nihar R. Desai & David Cornutt. (2019) Reversal agents for direct oral anticoagulants: considerations for hospital physicians and intensivists. Hospital Practice 47:3, pages 113-122.
Read now

Articles from other publishers (3)

O. M. Nesterova, Y. R. Lentsik, A. A. Vitik, E. D. Kosmacheva, V. I. Fetisova & M. N. Zamyatin. (2022) Use of idarucizumab for emergency surgery in patients taking dabigatran. Aterotromboz = Atherothrombosis 11:2, pages 76-86.
Crossref
Małgorzata M. Miller, Jessica Lowe, Muhib Khan, Muhammad U. Azeem, Susanne Muehlschlegel, Adalia H. Jun-O’Connell, Richard P. GoddeauJr.Jr., Majaz Moonis, Danielle Gritters, Brian Silver & Nils Henninger. (2019) Clinical and Radiological Characteristics of Vitamin K Versus Non-Vitamin K Antagonist Oral Anticoagulation-Related Intracerebral Hemorrhage. Neurocritical Care 31:1, pages 56-65.
Crossref
Adam J. SingerSusan Wilson. (2017) Reversal Strategies for Newer Oral Anticoagulants. AACN Advanced Critical Care 28:4, pages 322-331.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.